CommercialCoverageHigh impact
Respiratory Devices: Incentive Spirometers, Vaporizers and Intermittent Positive Pressure Breathing Machines (CPB 0479, reviewed 2026-07-09)
Aetna·Pulmonology, Critical Care, General Surgery +5 more·Medical Policy
Effective date
Jul 9, 2026
We identified it
Aug 15, 2026
Summary
Aetna updated its coverage policy for respiratory devices (CPB 0479, effective 2026-07-09). Incentive spirometers are now covered only for post-operative use in patients with neuromuscular or chest wall diseases; IPPB machines are covered for asthma, COPD, and other respiratory diseases. Vaporizers remain non-covered. Multiple other indications (including pre-operative use, COVID-19 treatment, spinal cord injury, and croup) are now explicitly classified as experimental/unproven and will be denied.
Action Required
By 2026-07-09: Billing team must update claim submission rules in billing software to deny coverage for all incentive spirometer (CPT 94640, A9284, E0487) and IPPB machine (E0500) claims that do not meet specific criteria: spirometers only for post-operative neuromuscular/chest wall disease patients; IPPB only for asthma/COPD/other respiratory diseases. Implement automated denials for non-covered indications including pre-operative use (cardiac surgery, bariatric surgery, abdominal surgery), COVID-19, long COVID, spinal cord injury, croup, sickle cell acute chest syndrome, cerebral palsy, and Down syndrome. Immediately stop billing E0605 (vaporizers) for all members—update billing system to automatically deny. Providers must document post-operative status and disease diagnosis on all respiratory device claims. Update encounter templates and pre-authorization workflows. Claims submitted without meeting criteria will be denied.